| Primary |
| Cancer Pain |
18.8% |
| Constipation |
12.5% |
| Delirium |
12.5% |
| Drug Use For Unknown Indication |
12.5% |
| Haemoptysis |
12.5% |
| Benign Prostatic Hyperplasia |
6.3% |
| Gastritis Prophylaxis |
6.3% |
| Hypertension |
6.3% |
| Non-small Cell Lung Cancer |
6.3% |
| Psychotic Disorder |
6.3% |
|
| Death |
25.0% |
| Pneumonitis |
25.0% |
| Product Name Confusion |
25.0% |
| Tremor Neonatal |
25.0% |
|
| Secondary |
| Schizophrenia |
32.6% |
| Product Used For Unknown Indication |
12.5% |
| Drug Use For Unknown Indication |
11.9% |
| Depression |
5.4% |
| Epilepsy |
4.5% |
| Constipation |
4.1% |
| Insomnia |
3.2% |
| Attention Deficit/hyperactivity Disorder |
3.0% |
| Nausea |
2.6% |
| Autism |
2.2% |
| Delirium |
2.2% |
| Delusion |
2.1% |
| Convulsion |
1.9% |
| Hallucination |
1.9% |
| Prophylaxis |
1.9% |
| Cancer Pain |
1.7% |
| Parkinsonism |
1.7% |
| Pharyngitis |
1.7% |
| Fluid Replacement |
1.5% |
| Pyrexia |
1.5% |
|
| Neuroleptic Malignant Syndrome |
14.6% |
| Pneumonia |
9.0% |
| Sydenham's Chorea |
9.0% |
| Toxic Epidermal Necrolysis |
6.7% |
| Metabolic Encephalopathy |
5.6% |
| Off Label Use |
4.5% |
| Persecutory Delusion |
4.5% |
| Platelet Count Increased |
4.5% |
| Psychomotor Skills Impaired |
4.5% |
| Pulmonary Embolism |
4.5% |
| Urinary Retention |
4.5% |
| Vomiting |
4.5% |
| Agranulocytosis |
3.4% |
| Cardiac Failure Acute |
3.4% |
| Death |
3.4% |
| Depressed Level Of Consciousness |
3.4% |
| Respiratory Failure |
3.4% |
| Hepatic Function Abnormal |
2.2% |
| Insomnia |
2.2% |
| Liver Disorder |
2.2% |
|
| Concomitant |
| Schizophrenia |
14.5% |
| Insomnia |
9.9% |
| Drug Use For Unknown Indication |
9.8% |
| Cancer Pain |
8.4% |
| Product Used For Unknown Indication |
6.9% |
| Constipation |
6.8% |
| Schizophrenia, Undifferentiated Type |
6.1% |
| Prophylaxis |
5.7% |
| Delirium |
4.1% |
| Pneumonia |
3.4% |
| Nausea |
3.0% |
| Schizophrenia, Paranoid Type |
3.0% |
| Hypertension |
2.9% |
| Depression |
2.8% |
| Multiple Myeloma |
2.4% |
| Epilepsy |
2.3% |
| Analgesic Therapy |
2.2% |
| Pain |
2.1% |
| Diabetes Mellitus |
1.9% |
| Hiv Infection |
1.8% |
|
| Renal Impairment |
11.6% |
| Shock |
11.1% |
| White Blood Cell Count Decreased |
10.6% |
| Vomiting |
6.8% |
| Weight Decreased |
6.3% |
| White Blood Cell Count Increased |
6.3% |
| Nausea |
5.3% |
| Respiratory Failure |
4.3% |
| Sepsis |
4.3% |
| Pyrexia |
3.9% |
| Thrombocytopenia |
3.9% |
| Wrong Technique In Drug Usage Process |
3.9% |
| Hepatic Function Abnormal |
2.9% |
| Malaise |
2.9% |
| Pulmonary Embolism |
2.9% |
| Tri-iodothyronine Decreased |
2.9% |
| Weight Increased |
2.9% |
| Acute Respiratory Distress Syndrome |
2.4% |
| Delirium |
2.4% |
| Interstitial Lung Disease |
2.4% |
|
| Interacting |
| Schizophrenia |
50.0% |
| Local Anaesthesia |
16.7% |
| Cognitive Disorder |
8.3% |
| Constipation |
8.3% |
| Depression |
8.3% |
| Peptic Ulcer |
8.3% |
|
| Pancytopenia |
33.3% |
| Withdrawal Syndrome |
33.3% |
| Drug Interaction |
16.7% |
| Post Procedural Complication |
16.7% |
|
